Krabbe Disease Treatment Global Market Report 2025
상품코드:1769632
리서치사:The Business Research Company
발행일:On Demand Report
페이지 정보:영문 175 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
크라베병 치료 시장 규모는 향후 수년간 강력한 성장이 전망됩니다. 2029년의 연간 평균 성장률(CAGR)은 6.4%로 성장할 전망이며, 31억 6,000만 달러로 성장이 예측됩니다. 예측 기간 동안 성장의 배경에는 유전자 치료 연구 증가, 희귀 질병 치료제 개발에 대한 투자 증가, 희귀 질병에 대한 규제 인센티브 강화, 임상 시험 활동 확대, 헬스케어 지출 증가가 있습니다. 주요 동향으로는 유전자 및 효소 보충 요법의 보급, 개별화 치료 접근법에 대한 주목, 줄기세포 이식의 진보, 진단 및 치료 개발에서 인공지능의 통합, 진단 기술의 향상 등을 들 수 있습니다.
신생아 스크리닝 프로그램의 실시 확대가 향후의 크라베병 치료 시장의 확대를 뒷받침할 것으로 예상되고 있습니다. 이러한 프로그램은 출생 직후의 유아를 대상으로, 위중한 가능성이 있으면서 치료 가능한 유전적, 대사적, 발달적 장애를 검사하는 보건상의 대처입니다. 의료 기술의 진보는 중요한 건강 문제의 조기, 보다 정확한 발견과 시기적절한 예방을 가능하게 함으로써 신생아 스크리닝의 증가에 기여하고 있습니다. 신생아 스크리닝은 크라베병의 조기 발견을 용이하게 하고 증상이 나타나기 전에 신속한 개입을 가능하게 합니다. 이 조기 진단은 환자의 예후를 개선하고 질병의 진행을 늦추는 줄기세포 이식과 같은 치료를 지원합니다. 예를 들어, 2023년 11월 미국 주 기관인 미시간주 보건복지국은 2022년까지 770만 명 이상의 유아가 스크리닝을 받았고, 8,000명 이상이 NBS 블러드스팟 패널에 의해 진단받았다고 보고했습니다. 구체적으로는 2022년 미시간주 주민을 중심으로 스크리닝을 받은 10만 176명의 영아 중 322명(0.3%)이 질환으로 진단됐습니다. 따라서 신생아 스크리닝 프로그램의 보급률 상승이 크라베병 치료 시장의 성장을 촉진하고 있습니다.
크라베병 치료 시장의 주요 기업은 치료 효과를 향상시키고 세계의 이용 가능성을 확대하기 위해 고급 유전자 치료 프로그램의 개발에 주력하고 있습니다. 유전자 치료에서는 환자의 세포 내 유전자를 변경하거나 치환함으로써 질병의 치료나 예방을 실시합니다. 이러한 치료법은 특정 유전자를 도입, 제거, 수정함으로써 유전적 결함을 수정하고자 하는 것으로 유전성 질환의 치료법 가능성을 제공합니다. 예를 들어 2024년 3월 미국 유전자치료회사 포지 바이오로직스는 신규 아데노 수반바이러스(AAV) 유전자치료제 FBX-101을 출시했습니다. 이 치료는 영국 의약품 및 헬스케어 제품규제청(MHRA)으로부터 혁신 패스포트를 지정받아 혁신적 라이선싱 액세스 패스웨이(ILAP)에 들어갈 수 있게 됐습니다. ILAP는 위중한 질환이나 생명을 위협하는 질환을 대상으로 하는 치료약의 약사 승인 및 시장 진입을 신속화하는 것을 목적으로 하고 있습니다. FBX-101은 초기 임상시험에서 유망한 안전성과 유효성을 보여주며, 기능적인 GALC 유전자를 환자에게 투여함으로써 기능합니다. FBX-101은 이 희귀하고 치사적인 신경변성 질환을 앓는 소아의 임상전귀를 개선하도록 디자인되어 있습니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향 및 전략
제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁 및 관세, 그리고 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석 및 전략 분석 프레임워크
세계의 크라베병 치료 : PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인 및 억제요인)
최종 이용 산업의 분석
세계의 크라베병 치료 시장 : 성장률 분석
세계의 크라베병 치료 시장 실적 : 규모 및 성장(2019-2024년)
세계의 쿠라베병 치료 시장 예측 : 규모 및 성장(2024-2029년, 2034년)
세계의 쿠라베병 치료 : 전체 시장 규모(TAM)
제6장 시장 세분화
세계의 크라베병 치료 시장 : 치료 유형별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
약
효소 보충 요법
유전자 치료
줄기세포 요법
세계의 크라베병 치료 시장 : 진단별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
신생아 스크리닝
유전자 검사
세계의 크라베병 치료 시장 : 유통 채널별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
소매 약국
전자상거래
병원 약국
세계의 크라베병 치료 시장 : 용도별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
유아기 발병
지발성
성인 발병
세계의 크라베병 치료 시장 : 최종 사용자별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
병원 및 진료소
연구센터
연구소
기타 최종 사용자
세계의 크라베병 치료 시장 : 의약품 유형별 세분화 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
항경련제
근육 이완제
항염증제
통증 관리제
향정신약
세계의 크라베병 치료 시장 : 효소 보충 요법(ERT) 유형별 세분화 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
정맥내 효소 주입
척수내 효소 투여
PEG화 효소 제형
재조합 갈락토세레브로시다아제(GALC)
세계의 크라베병 치료 시장 : 유전자 치료 유형별 세분화 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
아데노 관련 바이러스(AAV)를 이용한 유전자 치료
렌티바이러스 벡터를 이용한 유전자 치료
생체내 유전자 치료
체외 유전자 변형 줄기 세포 요법
세계의 크라베병 치료 시장 : 줄기 세포 치료 유형별 세분화 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
조혈 줄기세포 이식(HSCT)
제대혈 줄기세포 요법
골수 이식
동종 줄기세포 요법
제7장 지역별 및 국가별 분석
세계의 크라베병 치료 시장 : 지역별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
세계의 크라베병 치료 시장 : 국가별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도 및 기업 프로파일
크라베병 치료 시장 : 경쟁 구도
크라베병 치료 시장 : 기업 프로파일
Labcorp Holdings Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
Ajinomoto Co. Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
Fulgent Genetics : 개요, 제품 및 서비스, 전략 및 재무 분석
Mayo Clinic Laboratories : 개요, 제품 및 서비스, 전략 및 재무 분석
Myriad Genetics Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
제31장 기타 주요 기업 및 혁신 기업
Passage Bio Inc.
PreventionGenetics
Greenwood Genetic Center
Magenta Therapeutics Inc.
Gain Therapeutics Inc.
Cells4Life Group LLP
DNA Labs India
M6P Therapeutics
MediciNova Inc.
Neurogene Inc.
Polaryx Therapeutics Inc.
Vascumab LLC
APTEEUS
Agilus Diagnostics
Medicover Genetics
제32장 세계 시장 경쟁 벤치마킹 및 대시보드
제33장 주요 인수합병(M&A)
제34장 최근 시장 동향
제35장 시장의 잠재력이 높은 국가, 부문 및 전략
크라베병 치료 시장(2029년) : 새로운 기회를 제공하는 국가
크라베병 치료 시장(2029년) : 새로운 기회를 제공하는 부문
크라베병 치료 시장(2029년) : 성장 전략
시장 동향에 기초한 전략
경쟁 전략
제36장 부록
AJY
영문 목차
영문목차
Krabbe disease treatment involves medical interventions aimed at managing symptoms and slowing the progression of this rare, often fatal genetic disorder affecting the nervous system. Key treatment options include hematopoietic stem cell transplantation (HSCT), which is most effective when performed early, alongside supportive care such as physical therapy, seizure control, nutritional support, and pain management.
The main types of treatment comprise medications, enzyme replacement therapy, gene therapy, and stem cell therapy. Medications like anticonvulsants and muscle relaxants help manage symptoms such as seizures and muscle stiffness to improve patients' quality of life. Diagnosis is commonly performed through newborn screening and genetic testing. Treatments are distributed via retail pharmacies, e-commerce platforms, and hospital pharmacies. Krabbe disease treatments apply to various forms, including infantile, late-onset, and adult-onset, and are utilized by hospitals, clinics, research centers, and laboratories.
The krabbe disease treatment market research report is one of a series of new reports from The Business Research Company that provides krabbe disease treatment market statistics, including the krabbe disease treatment industry global market size, regional shares, competitors with the krabbe disease treatment market share, detailed krabbe disease treatment market segments, market trends, opportunities, and any further data you may need to thrive in the krabbe disease treatment industry. This krabbe disease treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The krabbe disease treatment market size has grown strongly in recent years. It will grow from $2.31 billion in 2024 to $2.47 billion in 2025 at a compound annual growth rate (CAGR) of 6.7%. The growth during the historic period can be attributed to the rising demand for rare disease treatments, increased research efforts in enzyme replacement therapy, expanded government funding for rare disease management, the proliferation of newborn screening programs, and strengthening patient advocacy initiatives.
The krabbe disease treatment market size is expected to see strong growth in the next few years. It will grow to $3.16 billion in 2029 at a compound annual growth rate (CAGR) of 6.4%. The growth in the forecast period can be attributed to increasing research in gene therapy, rising investments in orphan drug development, enhanced regulatory incentives for rare diseases, expanding clinical trial activities, and growing healthcare expenditure. Major trends include the wider adoption of gene and enzyme replacement therapies, a focus on personalized treatment approaches, advancements in stem cell transplantation, integration of artificial intelligence in diagnosis and therapy development, and improvements in diagnostic technologies.
The growing implementation of newborn screening programs is anticipated to boost the expansion of the krabbe disease treatment market in the future. These programs are health initiatives that test infants shortly after birth for potentially serious yet treatable genetic, metabolic, and developmental disorders. Advances in medical technology are contributing to the rise of newborn screening by allowing earlier, more accurate detection and timely prevention of critical health problems. Newborn screening facilitates the early identification of krabbe disease, enabling swift interventions before symptoms appear. This early diagnosis supports treatments like stem cell transplantation, which enhances patient outcomes and slows disease progression. For example, in November 2023, the Michigan Department of Health and Human Services, a US state agency, reported that by 2022, over 7.7 million infants had been screened, with more than 8,000 diagnosed through the NBS blood spot panel. Specifically, out of 100,176 infants screened in 2022, mostly Michigan residents, 322 (0.3%) were diagnosed with a condition. Hence, the rising prevalence of newborn screening programs is fueling growth in the krabbe disease treatment market.
Key companies in the krabbe disease treatment market are concentrating on developing advanced gene therapy programs to improve treatment efficacy and expand global availability. Gene therapy involves altering or replacing genes within a patient's cells to treat or prevent illnesses. These therapies seek to correct genetic defects by introducing, removing, or modifying specific genes, offering potential cures for genetic disorders. For example, in March 2024, Forge Biologics, a US-based gene therapy firm, launched FBX-101, a novel adeno-associated viral (AAV) gene therapy. This treatment received the Innovation Passport designation from the UK's Medicines and Healthcare Products Regulatory Agency (MHRA), allowing it to enter the Innovative Licensing and Access Pathway (ILAP). ILAP aims to expedite regulatory approval and market access for therapies targeting severe or life-threatening diseases. FBX-101 has shown promising safety and effectiveness in early clinical trials and functions by delivering a functional GALC gene to patients. It is designed to enhance clinical outcomes for children suffering from this rare and fatal neurodegenerative disorder.
In November 2023, Ajinomoto Co., Inc., a biotechnology and food company based in Japan, acquired Forge Biologics Holdings, LLC for $554 million. This acquisition allows Ajinomoto to expand its footprint in the gene therapy sector and enhance its biopharma services business. It supports Ajinomoto's ASV Initiatives 2030 Roadmap, which aims to position healthcare as a key growth area by integrating advanced gene therapy development and manufacturing capabilities. Forge Biologics Holdings LLC is a US-based company specializing in gene therapy for krabbe disease.
Major players in the krabbe disease treatment market are Labcorp Holdings Inc., Ajinomoto Co. Inc., Fulgent Genetics, Mayo Clinic Laboratories, Myriad Genetics Inc., Passage Bio Inc., PreventionGenetics, Greenwood Genetic Center, Magenta Therapeutics Inc., Gain Therapeutics Inc., Cells4Life Group LLP, DNA Labs India, M6P Therapeutics, MediciNova Inc., Neurogene Inc., Polaryx Therapeutics Inc., Vascumab LLC, APTEEUS, Agilus Diagnostics, and Medicover Genetics.
North America was the largest region in the krabbe disease treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in krabbe disease treatment report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the krabbe disease treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The krabbe disease treatment market consists of revenues earned by entities providing services such as genetic counseling, enzyme activity testing, hematopoietic stem cell transplantation (HSCT), and supportive care management. The market value includes the value of related goods sold by the service provider or included within the service offering. The krabbe disease treatment market also includes sales of viral vectors, infusion equipment, diagnostic kits, and neurological monitoring systems. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Krabbe Disease Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on krabbe disease treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for krabbe disease treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The krabbe disease treatment market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
3) By Gene Therapy: Adeno-Associated Virus (AAV)-Based Gene Therapy; Lentiviral Vector-Based Gene Therapy; In Vivo Gene Therapy; Ex Vivo Gene-Modified Stem Cell Therapy
3. Krabbe Disease Treatment Market Trends And Strategies
4. Krabbe Disease Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
5. Global Krabbe Disease Treatment Growth Analysis And Strategic Analysis Framework
5.1. Global Krabbe Disease Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Krabbe Disease Treatment Market Growth Rate Analysis
5.4. Global Krabbe Disease Treatment Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Krabbe Disease Treatment Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Krabbe Disease Treatment Total Addressable Market (TAM)
6. Krabbe Disease Treatment Market Segmentation
6.1. Global Krabbe Disease Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Medication
Enzyme Replacement Therapy
Gene Therapy
Stem Cell Therapy
6.2. Global Krabbe Disease Treatment Market, Segmentation By Diagnostics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Newborn Screening
Genetic Testing
6.3. Global Krabbe Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Retail Pharmacies
E-Commerce
Hospital Pharmacies
6.4. Global Krabbe Disease Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Infantile Onset
Late-Onset
Adult Onset
6.5. Global Krabbe Disease Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals And Clinics
Research Centers
Laboratories
Other End-Users
6.6. Global Krabbe Disease Treatment Market, Sub-Segmentation Of Medication, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Anticonvulsants
Muscle Relaxants
Anti-Inflammatory Drugs
Pain Management Medications
Psychotropic Agents
6.7. Global Krabbe Disease Treatment Market, Sub-Segmentation Of Enzyme Replacement Therapy (ERT), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Intravenous Enzyme Infusion
Intrathecal Enzyme Administration
PEGylated Enzyme Formulations
Recombinant Galactocerebrosidase (GALC)
6.8. Global Krabbe Disease Treatment Market, Sub-Segmentation Of Gene Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Adeno-Associated Virus (AAV)-Based Gene Therapy
Lentiviral Vector-Based Gene Therapy
In Vivo Gene Therapy
Ex Vivo Gene-Modified Stem Cell Therapy
6.9. Global Krabbe Disease Treatment Market, Sub-Segmentation Of Stem Cell Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hematopoietic Stem Cell Transplantation (HSCT)
Umbilical Cord Blood Stem Cell Therapy
Bone Marrow Transplant
Allogeneic Stem Cell Therapy
7. Krabbe Disease Treatment Market Regional And Country Analysis
7.1. Global Krabbe Disease Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Krabbe Disease Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Krabbe Disease Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Krabbe Disease Treatment Market, Segmentation By Diagnostics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Krabbe Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Krabbe Disease Treatment Market
9.1. China Krabbe Disease Treatment Market Overview
9.2. China Krabbe Disease Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Krabbe Disease Treatment Market, Segmentation By Diagnostics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Krabbe Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Krabbe Disease Treatment Market
10.1. India Krabbe Disease Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Krabbe Disease Treatment Market, Segmentation By Diagnostics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Krabbe Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Krabbe Disease Treatment Market
11.1. Japan Krabbe Disease Treatment Market Overview
11.2. Japan Krabbe Disease Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Krabbe Disease Treatment Market, Segmentation By Diagnostics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Krabbe Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Krabbe Disease Treatment Market
12.1. Australia Krabbe Disease Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Krabbe Disease Treatment Market, Segmentation By Diagnostics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Krabbe Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Krabbe Disease Treatment Market
13.1. Indonesia Krabbe Disease Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Krabbe Disease Treatment Market, Segmentation By Diagnostics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Krabbe Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Krabbe Disease Treatment Market
14.1. South Korea Krabbe Disease Treatment Market Overview
14.2. South Korea Krabbe Disease Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Krabbe Disease Treatment Market, Segmentation By Diagnostics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Krabbe Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Krabbe Disease Treatment Market
15.1. Western Europe Krabbe Disease Treatment Market Overview
15.2. Western Europe Krabbe Disease Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Krabbe Disease Treatment Market, Segmentation By Diagnostics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Krabbe Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Krabbe Disease Treatment Market
16.1. UK Krabbe Disease Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Krabbe Disease Treatment Market, Segmentation By Diagnostics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Krabbe Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Krabbe Disease Treatment Market
17.1. Germany Krabbe Disease Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Krabbe Disease Treatment Market, Segmentation By Diagnostics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Krabbe Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Krabbe Disease Treatment Market
18.1. France Krabbe Disease Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Krabbe Disease Treatment Market, Segmentation By Diagnostics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Krabbe Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Krabbe Disease Treatment Market
19.1. Italy Krabbe Disease Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Krabbe Disease Treatment Market, Segmentation By Diagnostics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Krabbe Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Krabbe Disease Treatment Market
20.1. Spain Krabbe Disease Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Krabbe Disease Treatment Market, Segmentation By Diagnostics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Krabbe Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Krabbe Disease Treatment Market
21.1. Eastern Europe Krabbe Disease Treatment Market Overview
21.2. Eastern Europe Krabbe Disease Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Krabbe Disease Treatment Market, Segmentation By Diagnostics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Krabbe Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Krabbe Disease Treatment Market
22.1. Russia Krabbe Disease Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Krabbe Disease Treatment Market, Segmentation By Diagnostics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Krabbe Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Krabbe Disease Treatment Market
23.1. North America Krabbe Disease Treatment Market Overview
23.2. North America Krabbe Disease Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Krabbe Disease Treatment Market, Segmentation By Diagnostics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Krabbe Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Krabbe Disease Treatment Market
24.1. USA Krabbe Disease Treatment Market Overview
24.2. USA Krabbe Disease Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Krabbe Disease Treatment Market, Segmentation By Diagnostics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Krabbe Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.2. Canada Krabbe Disease Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Krabbe Disease Treatment Market, Segmentation By Diagnostics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Krabbe Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Krabbe Disease Treatment Market
26.1. South America Krabbe Disease Treatment Market Overview
26.2. South America Krabbe Disease Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Krabbe Disease Treatment Market, Segmentation By Diagnostics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Krabbe Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Krabbe Disease Treatment Market
27.1. Brazil Krabbe Disease Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Krabbe Disease Treatment Market, Segmentation By Diagnostics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Krabbe Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Krabbe Disease Treatment Market
28.1. Middle East Krabbe Disease Treatment Market Overview
28.2. Middle East Krabbe Disease Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Krabbe Disease Treatment Market, Segmentation By Diagnostics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Krabbe Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Krabbe Disease Treatment Market
29.1. Africa Krabbe Disease Treatment Market Overview
29.2. Africa Krabbe Disease Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Krabbe Disease Treatment Market, Segmentation By Diagnostics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Krabbe Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Krabbe Disease Treatment Market Competitive Landscape And Company Profiles
